Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation. [electronic resource]
- The Journal of clinical endocrinology and metabolism 06 2017
- 2112 p. digital
Publication Type: Letter; Comment
1945-7197
10.1210/jc.2017-00096 doi
Bone Density Conservation Agents Denosumab Humans Osteoporosis, Postmenopausal Osteoporotic Fractures Spinal Fractures